Company intelligence / Profile preview

HBM Partners

Ownership: Private
Development stage: Other

Overview

HBM Partners is a Swiss-based healthcare investment firm managing over $2.1 billion in assets. It focuses on venture capital and private equity investments in private and public biopharma, medtech, diagnostics and health IT companies globally. The firm has supported over 100 investments resulting in more than 60 trade sales or IPOs since its founding in 2001. Its strategy emphasizes value creation through active engagement with portfolio companies at all stages of development.

Therapeutic areas: Rare DiseasesImmunologyOncologyNeurology
Modalities: Small moleculeMonoclonal antibodyGene therapyRNA therapyCell therapyProtein degraders
Industry: Investors

Partnerships

Collaborates closely with other specialized investors globally.Maintains relationships with founders/scientists/industry leaders to source deals.

Beyond the preview

Go deeper on HBM Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HBM Partners.

Explore the full profile